PMID: 8970497Dec 1, 1996Paper

Recent trends in the consumption of lipid-lowering drugs in Finland

Journal of Clinical Epidemiology
J MartikainenH Wahlroos

Abstract

The consumption of lipid-lowering drugs in Finland and in other Nordic countries increased almost steadily in 1988-1993. The exceptions were the year 1992 in Finland and 1993 in Iceland, when consumption was lower than in the previous year. In both cases the temporary decline in consumption was associated with a reduction in reimbursement for the costs of lipid-lowering drugs. In 1993, the consumption level was 2.7 defined daily doses/1000 inhabitants/day in Finland and ranged from 2.3 to 4.0 in other Nordic countries. According to the Finnish nationwide prescription register, 0.5% of men and 0.6% of women purchased lipid-lowering drugs in the period from January to September, 1994. The rate of use was highest among people of middle age. In the early 1990s, statins took the lead in the consumption of lipid-lowering drugs, accounting for 70% of prescriptions in 1993; the percentages of fibrates, resins, and nicotinic acid derivatives declined in the same period. In 1994 the prevalence of familial hypercholesterolemia (FH) according to strictly predetermined criteria was 0.8 per 1000 among Finns, and the proportion of FH patients among all users of lipid-lowering drugs was 11%. The use of lipid-lowering drugs is not particularly ...Continue Reading

References

Feb 15, 1992·BMJ : British Medical Journal·G Davey Smith, J Pekkanen
May 1, 1989·Circulation·G A Reynolds
Jan 1, 1989·International Journal of Epidemiology·U Keil, K Kuulasmaa
Jan 1, 1971·Annals of Internal Medicine·W B KannelP M McNamara
Oct 1, 1994·Journal of Clinical Epidemiology·E F Boumendil

❮ Previous
Next ❯

Citations

Jan 10, 2002·Journal of Clinical Epidemiology·Isabelle Savoie, Arminée Kazanjian
Apr 23, 2002·British Journal of Clinical Pharmacology·Aukje K Mantel-TeeuwisseAnthonius de Boer
Nov 16, 2014·BMC Research Notes·Antti TanskanenJari Tiihonen
Sep 11, 2008·British Journal of Clinical Pharmacology·Päivi RuokoniemiRisto Huupponen
Dec 15, 2007·British Journal of Clinical Pharmacology·Jarir AtthobariUNKNOWN PREVEND study group
Oct 25, 2011·Atencion primaria·Juan Simó Miñana
Nov 26, 2008·Pharmacoepidemiology and Drug Safety·J KrappweisW Kirch
Oct 10, 2007·Pharmacoepidemiology and Drug Safety·Chi-Wen ChiangChun-Yuh Yang
Oct 28, 2004·Pharmacoepidemiology and Drug Safety·Zdenek KuceraMiroslava Hejdova

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.